PD-L1 expression on immune cells is a favorable prognostic factor for vulvar squamous cell carcinoma patients

BACKGROUND: Anti-immune programmed death-ligand 1 (PD-L1) pathway is used by the tumor to overcome immune system and serves as immunotherapy target in various malignancies. AIM: To investigate the expression of PD-L1 in vulvar squamous cell carcinoma (vSCC) and to assess it's clinicopathologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Sznurkowski, Jacek J., Żawrocki, Anton, Sznurkowska, Katarzyna, Pęksa, Rafał, Biernat, Wojciech
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685718/
https://www.ncbi.nlm.nih.gov/pubmed/29163797
http://dx.doi.org/10.18632/oncotarget.20911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685718/
https://www.ncbi.nlm.nih.gov/pubmed/29163797
http://dx.doi.org/10.18632/oncotarget.20911

Ejemplares similares